Global Custom Market Research Reports Provider Company

phone

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2017

  • Published Date: 30 Jun 2017
  • Number of Pages: 1085
  • Category: Healthcare and Medical
  • Country: Global
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2017

Summary

GlobalDatas clinical trial report, Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Publisher Name : GlobalData
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials 22
Clinical Trials by Phase in E7 Countries 24
Clinical Trials in E7 Countries by Trial Status 25
Clinical Trials by Phase 27
In Progress Trials by Phase 28
Clinical Trials by Trial Status 29
Clinical Trials by End Point Status 31
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials 36
Prominent Drugs 38
Latest Clinical Trials News on Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) 40
Jun 23, 2017: Novartis data shows half of eligible Ph+ CML-CP patients remain in Treatment-free Remission nearly two years after stopping Tasigna 40
Jun 05, 2017: Early, Durable Responses Seen with Sprycel (dasatinib) in First- and Second-Line Treatment of Pediatric Patients with Chronic Myeloid Leukemia in Chronic Phase (CP-CML) 41
Clinical Trial Profile Snapshots 42
Appendix 1083
Abbreviations 1083
Definitions 1083
Research Methodology 1084
Secondary Research 1084
About GlobalData 1085
Contact Us 1085
Disclaimer 1085
Source 1085

List Of Tables


Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Region, 2017* 8
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 15
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 16
Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, G7 Countries (%), 2017* 18
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 21
Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, E7 Countries (%), 2017* 23
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 26
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Phase, 2017* 27
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 28
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 30
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 33
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 35
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 37
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 39

List Of Figures


Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 15
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 16
Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, G7 Countries (%), 2017* 17
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) to Oncology Clinical Trials, E7 Countries (%), 2017* 22
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 27
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 28
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 33
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 38
GlobalData Methodology 1084

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2017 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline

View Report

Chronic Cough Global Clinical Trials Review, H2, 2017 GlobalDatas clinical trial report, Chronic Cough Global Clinical Trials Review, H2, 2017 provides an overview of Chronic Cough clinical trials scenario. This report

View Report

Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2017 GlobalDatas clinical trial report, Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2017 provides an overview of Hyperphosphatemia

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports